Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
Jang Hyun Park, Heung Kyu Lee
Cancers (2022) Vol. 14, Iss. 5, pp. 1176-1176
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives
Ilaria Salvato, Antonio Marchini
Cancers (2024) Vol. 16, Iss. 7, pp. 1276-1276
Open Access | Times Cited: 17
Advancing glioblastoma treatment by targeting metabolism
Jinyi Zhao, Xue-Mei Ma, Peixian Gao, et al.
Neoplasia (2024) Vol. 51, pp. 100985-100985
Open Access | Times Cited: 16
Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs
Shengwen Shao, Huilai Miao, Wenxue Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence
Geoffroy Andrieux, Tonmoy Das, Michaela Griffin, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment
Ryusuke Hatae, Keith Kyewalabye, Akane Yamamichi, et al.
JCI Insight (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 11
A new application of fractional derivatives for predicting human glioblastoma multiforme tumor growth
M. Hosseininia, Omid Bavi, Mohammad Heydari, et al.
Engineering Analysis with Boundary Elements (2024) Vol. 165, pp. 105776-105776
Closed Access | Times Cited: 8
Glioblastoma multiforme growth prediction using a Proliferation-Invasion model based on nonlinear time-fractional 2D diffusion equation
Omid Bavi, M. Hosseininia, Mojtaba Hajishamsaei, et al.
Chaos Solitons & Fractals (2023) Vol. 170, pp. 113393-113393
Closed Access | Times Cited: 20
Photodynamic therapy for glioblastoma: A light at the end of the tunnel
Mariana Miretti, María Antonella González Graglia, Agustín I. Suárez, et al.
Journal of Photochemistry and Photobiology (2023) Vol. 13, pp. 100161-100161
Open Access | Times Cited: 19
Pleiotropic effects of the COX-2/PGE2 axis in the glioblastoma tumor microenvironment
Phillip T. Dean, Shelley B. Hooks
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 17
Development of a 3D Tumor Spheroid Model from the Patient’s Glioblastoma Cells and Its Study by Metabolic Fluorescence Lifetime Imaging
D V Yuzhakova, Maria M. Lukina, D A Sachkova, et al.
Sovremennye tehnologii v medicine (2023) Vol. 15, Iss. 2, pp. 28-28
Open Access | Times Cited: 16
Emerging Lipid Targets in Glioblastoma
Ammar Darwish, Milán Pammer, Ferenc Gallyas, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 397-397
Open Access | Times Cited: 7
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
Megan Montoya, Marco Gallus, Su Phyu, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 726-726
Open Access | Times Cited: 6
Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data
Dimitra Smerdi, Myrto Moutafi, Ioannis Kotsantis, et al.
Life (2024) Vol. 14, Iss. 6, pp. 673-673
Open Access | Times Cited: 6
Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy
Selda Abyar, Luojiao Huang, Yurii Husiev, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11086-11102
Open Access | Times Cited: 6
Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets
Ashley Irin Cortes Ballen, Maryam Amosu, Surya Ravinder, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1574-1574
Open Access | Times Cited: 6
Understanding the Significance of Hypoxia-Inducible Factors (HIFs) in Glioblastoma: A Systematic Review
Emir Begagić, Hakija Bečulić, Amina Džidić-Krivić, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2089-2089
Open Access | Times Cited: 5
Emerging Approaches in Glioblastoma Treatment: Modulating the Extracellular Matrix Through Nanotechnology
Miguel Horta, Paula Soares, Catarina Leite Pereira, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 142-142
Open Access
Growth of the prefrontal cortical glioblastoma altered cognitive and emotional behaviors via mediating miRNAs and GABA-A receptor signaling pathways in rats
Sepide Nateghi, Ameneh Rezayof, Fatemeh Kouhkan, et al.
Brain Research Bulletin (2025), pp. 111227-111227
Open Access
Nanozyme-Based Cancer Nanotheranostics: Emerging Applications and Challenges in Brain Cancer Therapeutics
Alexandra A.P. Mansur, Herman S. Mansur
Journal of Nanotheranostics (2025) Vol. 6, Iss. 1, pp. 4-4
Open Access
Why Do Glioblastoma Treatments Fail?
Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, et al.
Future Pharmacology (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Multi-omics analysis identifies novels genes involved in glioma prognosis
Yingjie Li, Hong Sun
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Targeting HIF-2α in glioblastoma reshapes the immune infiltrate and enhances response to immune checkpoint blockade
Felipe I. Espinoza, Stoyan Tankov, Sylvie Chliate, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Photodynamic Opening of the Blood–Brain Barrier and the Meningeal Lymphatic System: The New Niche in Immunotherapy for Brain Tumors
Oxana Semyachkina‐Glushkovskaya, Andrey Terskov, Alexander Khorovodov, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2612-2612
Open Access | Times Cited: 19
A syngeneic spontaneous zebrafish model of tp53-deficient, EGFRvIII, and PI3KCAH1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo
A. H. Weiss, Cassandra D’Amata, Bret J. Pearson, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 4
Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach
Clara Bayona, Lía Alza, Teodora Ranđelović, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top